Skip to content
  • RESEARCH
  • PUBLICATIONS
  • TEAM
  • LAB NEWS
  • CONTACT
  • RESEARCH
  • PUBLICATIONS
  • TEAM
  • LAB NEWS
  • CONTACT

© 2019

Overview of genetically engineered mouse models of colorectal carcinoma to enable translational biology and drug development.

RoperJ, Martin ES, Hung KE.

Overview of genetically engineered mouse models of colorectal carcinoma to enable translational biology and drug development.

Curr Protoc Pharmacol. 2014 Jun 16;65:14.29.1-14.2910. PMID: 24934606

2014

Tags
2014

Post navigation

Previous post Cross-species analysis of genetically engineered mouse models of MAPK-driven colorectal cancer identifies hallmarks of the human disease.

Post navigation

Next post Co-occurrence of idiopathic granulomatous hepatitis and primary biliary cirrhosis.
Recent Posts
  • Weight Loss and/or Sulindac Mitigate Obesity-associated Transcriptome, Microbiome, and Protumor Effects in a Murine Model of Colon Cancer
  • CAUSE, EPIDEMIOLOGY, AND HISTOLOGY OF POLYPS AND PATHWAYS TO COLORECTAL CANCER
  • SPECTROSCOPIC OPTICAL COHERENCE TOMOGRAPHY FOR CLASSIFICATION OF COLORECTAL CANCER IN A MOUSE MODEL
  • METABOLISM AND COLORECTAL CANCER
  • MIRROR MIRROR ON THE WALL, WHO IS THE FITTEST OF THEM ALL: A NOVEL PREDICTION MODEL FOR POSTOPERATIVE HEPATIC DECOMPENSATION IN PATIENTS WITH CIRRHOSIS
Archives
  • April 2023
  • January 2022
  • February 2020
  • January 2020
Categories
  • Publications
Meta
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
© 2025 Roper Labs. Created for free using WordPress and Colibri